Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study
Guselkumab is a new treatment for improving Crohn’s disease with a patient-friendly administration option. Guselkumab injections resulted in meaningful improvements in symptoms and the lining of the intestine.
